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ABSTRACT
Carlson, Cataleya. M.S., Department of Pharmacology and Toxicology, Wright State
University, 2006. In vitro Toxicity Assessment of Silver Nanoparticles in Rat Alveolar
Macrophages.

The present study was conducted to assess the toxicity of nanosized silver particles (Ag15nm, 30nm and 55nm) in rat alveolar macrophages. For toxicity evaluations, cellular
morphology, mitochondrial function (MTT assay), membrane leakage (LDH assay) and
reactive oxygen species generation (ROS) were assessed after a 24h under control and
exposed conditions. The morphological appearance of control and exposed cells were
observed by an inverted, phase contrast microscope and the uptake of nanoparticles was
observed using the CytoViva Ultra Resolution Imaging (URI) system. Morphological
images captured at 100x magnification demonstrated that nanoparticle-exposed cells at
higher doses became abnormal in size, and most of the cells were detached from the
bottom of the cultured plates. It was also noted that agglomerates of nanoparticles were
surrounded by macrophages; while some attached to the cell membrane. Further analysis
of CytoViva URI system images exhibit the uptake of agglomerates into macrophages.
The results of the biochemical studies revealed that cells exposed to Ag-15nm and 30nm
for 24h showed a dose-dependent decrease in mitochondrial function. Calculated EC50
values from MTT data indicate that Ag-15nm and Ag-30nm are more toxic at lower
concentrations when compared to Ag-55nm. In correlation with decreased mitochondrial
function and subsequent lack of ATP production, cell viability assays also demonstrated a
sizeable decrease in the number of viable cells exposed to Ag-15nm and 30nm, including
at the lowest dose (5µg/ml). ROS date further supported a size and dose dependent
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relationship, with a 15.16 ±5.77 fold increase in ROS generation at 50 µg/ml of Ag15nm. Preliminary apoptosis results reveal a size-dependent increase in caspase 3&7
enzyme activity; an indicator of apoptosis. In conclusion, data reveal that the size of the
nanoparticle is a potential contributing factor in exhibiting toxicity, as Ag-15nm is found
to be the most toxic when compared to larger nanoparticles (30nm and 55nm). The study
also suggests that the mechanism of toxicity is likely due to the generation of reactive
oxygen species, inducing oxidative stress and resulting in apoptosis.

iv

ACKNOWLEDGMENTS
I would like to thank Col Riddle, Biosciences and Protection Division Chief, Dr.
Schlager and Maj Johnson, Applied Biotechnology Branch Chief and Deputy Chief, my
committee members, Dr. Lucot and Dr. Cool, and especially my advisor, Dr. Hussain for
their support, guidance and encouragement. Dr. Hussain has been instrumental in my
success as an officer, a scientist and a student and I am grateful for the opportunity to
work with him. Thank you to Maria Palazuelos and Dr Kevin Powers of the University
of Florida Particle Engineering Research Center for their help in the characterization of
the nanoparticles. I would also like to acknowledge the members of the Biological
Interactions of Nanomaterials (BIN) group for all their hard work. Lastly, I would like to
thank my family and my friends for their constant support, motivation and faith.

v

TABLE OF CONTENTS
Abstract ..........................................................................................................iii
Acknowledgments..........................................................................................v
Table of Contents...........................................................................................vi
List of Figures ................................................................................................vii
List of Tables .................................................................................................viii
List of Abbreviations .....................................................................................ix
I.
INTRODUCTION
a. Background ..........................................................................1
b. Nanoparticles .......................................................................2
c. Exposure and Risk Assessment ...........................................6
d. Anatomy of the Lung ...........................................................8
e. Silver Toxicity ...................................................................11
II.
PURPOSE ................................................................................13
III.
HYPOTHESIS .........................................................................16
a. Specific Aims.....................................................................16
IV.
EXPERIMENTAL APPROACH
a. Chemicals and Reagents ....................................................17
b. Cell Culture Techniques ....................................................18
c. Dispersion Tests.................................................................20
d. Treatment Protocol.............................................................21
e. Nanoparticle Characterization ...........................................23
f. Morphology........................................................................25
i. Qualitative observation ..........................................25
ii. Uptake ....................................................................25
g. Mitochondrial Function .....................................................26
h. Membrane Integrity ...........................................................28
i. Oxidative Stress .................................................................30
j. Statistical Evaluation .........................................................33
V.
RESULTS
a. Dispersion Tests.................................................................34
b. Nanoparticle Characterization ...........................................39
c. MTT Assay ........................................................................42
d. LDH Assay.........................................................................46
e. ROS Assay .........................................................................48
f. Morphology........................................................................50
VI.
DISCUSSION ..........................................................................55
VII. REFERENCES ........................................................................62

vi

LIST OF FIGURES
Figure 1. Size comparison chart ....................................................................3
Figure 2. Anatomy of lung ............................................................................9
Figure 3. Schematic diagram summarizing study outline..............................15
Figure 4. Treatment protocol .........................................................................22
Figure 5. Diagram of colorimetric MTT assay ..............................................27
Figure 6. Diagram of fluorescent LDH assay ................................................29
Figure 7. Diagram of fluorescent ROS assay.................................................32
Figure 8. Dispersion test ................................................................................36
Figure 9. Dosing solution protocol ................................................................37
Figure 10. Digital image of turbidity of dosing solutions..............................38
Figure 11. TEM images of silver nanoparticles.............................................41
Figure 12. Effect of CdO on mitochondrial function (MTT assay) ..............43
Figure 13. Effect of silver nanoparticles on mitochondrial function
(MTT assay).................................................................................44
Figure 14. Effect of silver nanoparticles on membrane integrity
(LDH assay). ................................................................................47
Figure 15. Generation of ROS and H2O2 standard curve..............................49
Figure 16. 20x Morphological images ...........................................................52
Figure 17. 100x Morphological images .........................................................53
Figure 18. CytoViva URI 60x images ...........................................................54

vii

LIST OF TABLES
Table 1. Area of deposition of particles.........................................................9
Table 2. Results of BET analysis of SSA .....................................................40
Table 3. EC50 and CT values of Ag-NP, AgNO34 and CdO ..........................45

viii

LIST OF ABBREVIATIONS
NP
NM
NT
CNT
QD
Al
Ag
Al-NP
Ag-NP
ROS
MTT
LDH
FBS
nm
ml
mg
µl
µg
AM
PAM
SA
PBS
dI H2O
DMSO
IPA
EC50
OD
HRP
BET
SD

nanoparticles
nanomaterials
nanotubes
carbon nanotubes
quantum dots
aluminum
silver
aluminum nanoparticle(s)
silver nanoparticle(s)
reactive oxygen species
(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide)
lactate dehydrogenase
fetal bovine serum
nanometer
milliliter
milligram
microliter
microgram
alveolar macrophages
pulmonary alveolar macrophages
surface area
phosphate buffered saline
deionized water
dimethylsulfoxide
isopropyl alcohol
concentration that causes 50% of desired effect
optical density
horseradish peroxidase
Brunauer, Emmet, Teller
standard deviation

ix

INTRODUCTION
Background
Nanotechnology involves the creation and manipulation of materials at nanoscale
levels to create products that exhibit novel properties. Engineered nanomaterials, or
nanoparticles (NP), are defined as materials produced within the range of 1-100 nm (109

m) in length or diameter. Nanomaterials possess increased structural integrity as well as

unique mechanical, optical, chemical, electrical and magnetic properties (Oberdorster et
al., 2005a; Thomas and Sayre, 2005).The unique function of these “nanomaterials”
directly depends on their size and structure-dependent properties, as do the environmental
and health effects. Nanoparticles are of particular concern due to their extremely high
surface area and increased reactivity. Because of these unique physical and chemical
properties, NP can potentially impact the health of those exposed to them during
industrial manufacturing and production. Nanomaterials have gained enormous attention
and are currently being widely used in modern technology. Although the applications and
benefits of these engineered nanomaterials are extensively, (Health and Safety Executive,
2004; Hoet et al., 2004; Thomas and Sayre, 2005) there is a severe lack of information
concerning the human health and environmental implications of occupational exposure
during the manufacturing and handling process.
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Nanomaterials/Nanoparticles
Nanoparticles are defined as “ultra-fine dispersed, solid particles (in the size range
of colloids), possessing a high specific surface to volume ratio” by www.Google.com.
Nanomaterials must possess at least one side between 1-100 nm in length. A single
nanometer (nm) is roughly the width of 10 hydrogen atoms. Figure 1 illustrates how
nanoparticles rank in scale compared to other common biological entities. For example,
the width of an amino acid is approximately 0.8nm; E. Coli bacterium is 2 µm in length
(2,000 nm); a red blood cell is 9 µm (9,000 nm); alveolar macrophages (AM’s) are
approximately 15 µm (15,000 nm); and the width of a strand of hair is 0.08 m (8 x 107
nm).
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1 mm = Head of a pin

0.08mm = Width of hair

10-50 µm = Most animal cells
~15 µm = Alveolar macrophage
2 µm = E. Coli bacterium
9 µm = Red blood cell
3-10 µm =
Nucleus
200-500nm = Lysosomes, peroxisomes

10nm = Mitochondria, cell membrane
2nm = DNA Alpha Helix
0.8nm = Amino acid
0.1nm = Hydrogen atom

Figure 1: Chart comparing sizes of biological entities.
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It has been reported that, physico-chemical properties of metallic nanoparticles
are highly influenced by shape and size (Brown et al., 2001; Muller et al., 2004). As
previously stated, the unique properties of various types of intentionally produced
nanomaterials make these particles novel electrical, catalytic, magnetic, mechanical,
thermal, or imaging substances that are highly desirable for applications in commercial,
medical, military, and environmental sectors. As we identify new uses for materials with
these special properties, the number of products containing such nanomaterials and their
possible applications continues to grow.
Applications
Current nanotechnology applications include the use of nanoparticles in
propulsion devices, sunscreens, cosmetics, paints, and as fuel additives (Al), drug
carriers, fluorophores (QD) for bio-imaging and as bactericidal agents (Ag) (VillalobosHernandez and Muller-Goymann, 2005). Recently, nanomaterials such as carbon
nanotubes (CNT), nanowires, quantum dots (Ghibelli et al., 2005), fullerene derivatives
(“buckyballs” or C60), metal, metal oxide and polymer NP have received enormous
attention for their ability to create new types of analytical tools for biotechnology and life
sciences.
Similar to nanotechnology’s success in consumer products and other sectors,
nanomaterials have promising environmental applications. For example, nano-sized
cerium oxide has been developed to decrease diesel emissions (Jung et al., 2005) and iron
nanoparticles can remove contaminants from soil and ground water. Nano-sized sensors
also have to potential to improve detection and tracking of contaminants.
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Nanosilver, typically ~20nm in diameter, is commonly used to fight infectious
diseases and is effective in retarding the growth of bacterium, mold, harmful spores,
germs, etc. Thus, nanosilver is found to be a popular constituent in health applications
from bone cements to drug carriers to antimicrobial fibers. Curad© Silver Bandages are
available over the counter with nanosilver woven into the “wound pad” as an
antibacterial agent. Ag-NP, approximately ~10nm in diameter, are being incorporated in
therapeutic cosmetics and skin care products designed for acne sufferers (MullerGoymann, 2004). Beyond health applications, nanosilver (~50nm in diameter) is being
added to the ink of ink jet printers, increasing the ability to print on difficult surfaces such
as glass (Kamyshny et al., 2005; Magdassi et al., 2003).
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Exposure and Risk Assessment
Some of the same special properties that make nanomaterials useful are also
properties that may cause some nanomaterials to pose hazards to humans and the
environment, under specific conditions. Some nanomaterials that enter animal tissues
may be able to pass through cell membranes or cross the blood-brain barrier (Oberdorster
et al., 2004). This may be a beneficial characteristic for such uses as targeted drug
delivery and other disease treatments, but could result in unintended impacts in other uses
or applications. Inhaled nanoparticles may become lodged in the lung, and the high
durability and reactivity of some nanomaterials raises issues of their fate in the
environment.
Although a few studies have found low concentrations of NP and CNT
particulates in the air during industrial processes(Maynard et al., 2004; Oberdorster et al.,
2000), a full assessment of exposure levels has yet to occur. Occupational exposure is
likely to occur through dermal contact, ingestion or inhalation. Therefore, NP could
potentially have an impact on the deep regions of the lung; in specific, the alveolar region
(Oberdorster, 2000; Zhang et al., 2005).
Several factors play a key role in the potential toxicity of silver nanoparticles.
First, NP possess a large SA to mass ratio which increases then number of sites to interact
with the cell membrane(Bene et al., 2005; Kim et al., 2006). A high SA to mass ratio
also enables NP to serve as transporters because of this varied interaction with
xenobiotics, pharmaceuticals and toxins. Second, studies have shown ultra fine particles
(<100nm) are more toxic than larger particles made of the same material partly due to a
decrease in clearance functions and a persistence in tissues (Zhang et al., 1998; Zhang et
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al., 2003). It is also hypothesized that “overloading” contributes to the decrease in
clearance functions. Interestingly, studies have shown that the structure of nanomaterials
(i.e. anatase vs. rutile) also plays a role in toxicity (Warheit et al., 2006). Lastly, the size
of the NP leads to enhanced deposition, allowing for easy access to deep regions of the
lung.
Among the limited studies conducted on the toxicity of nanoparticles are little
reports on the use of in vitro models to evaluate potential toxicity screening of
nanomaterials and their mechanism of action. In vitro studies are conducted initially
(Castell et al., 1997)and are ideal in research because of their ability to rapidly and
inexpensively produce viable results without the use of animals. Recently, data reported
on the cytotoxicity testing of series of high energy chemicals in an in vitro model
(Hussain and Frazier, 2002; Hussain et al., 2005)were used to derive a baseline for
extrapolation to a human health risk assessment (Trohalaki et al., 2002). Although, in
vitro data is not a substitute for whole animal studies, use of simple in vitro models with
end points that reveal a general mechanism of toxicity can be a basis for further assessing
the potential risk of chemical/material exposure.
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Anatomy of the Lung
The lung consists of two general regions: the upper and lower airways.
The upper airway is responsible for the transportation of air in/out of the lungs and the
lower airway is responsible for gas exchange (Casarett et al., 2001). Deposition of
foreign particles depends greatly, but not inclusively, on size. As shown in Figure 2 and
Table 1, the majority of particles inhaled between 5-30 µm in diameter will reach the
nasopharyngeal region and likely be cleared by sneezing, coughing, etc. Particles
between 1-5 µm will find their way into the trachea, bronchial and bronchiolar region,
posing a slightly higher risk than the larger particles. Clearance of these micron sized
particles is likely to occur through the mucociliary escalator. Lastly, particles at <1 µm
will reach the deep regions of the lung: the alveolar sacs (Oberdorster et al., 2002;
Takenaka et al., 2001). Upon reaching the alveoli, if not initially cleared by the
mucociliary escalator, particles are ingested via phagocytosis by pulmonary alveolar
macrophages (PAM), which reside in the alveolar sacs and line the alveolar epithelium.
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Figure 2: Anatomy of the lung depicting various components of the human
airway and lung.

Size of particle

Area of deposition

5-30 μm

Nasopharyngeal Region
(Upper airway passages - nose and throat)
Trachea, Bronchial and
Bronchiolar Region
(windpipe and larger branches of the lungs)
Alveolar Region
(Smaller branches of lung and the air exchange area)

1-5 μm

<1 μm

Table 1: Area of deposition of inhaled particulates based on size only.
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Alveolar macrophages
Human lungs contain approximately 109 AM (Freitas, 2003). Macrophages are
generally a population of ubiquitously distributed mononuclear phagocytes responsible
for numerous homeostatic, immunological, and inflammatory processes. Their primary
function is to act as scavengers, roaming the lungs, engulfing foreign matter and
potentially dangerous matter. Alveolar macrophages are known to be extremely effective
in the clearance of foreign matter; internalizing 80-85% of particulates attached to the
membrane via phagocytosis and endocytosis (Lipscomb and Russell, 1997).
In vivo exposure to nanoparticles is likely to occur through inhalation, dermal
contact and ingestion. Deposition of inhaled particulate matter is dependent on size;
consequently silver nanoparticles are likely to have an effect on the deep regions of the
lung; in specific, the alveolar region (Jani et al., 1990). Therefore, in the present study rat
alveolar macrophages were selected as a model cell line to assess the level of toxicity and
explore possible mechanisms of toxicity through inhalation.

10

Silver Toxicity
Several studies have demonstrated the importance of nano-silver as an antibactericidal agent (Alt et al., 2004; Morones et al., 2005; Son et al., 2004). However, few
studies have investigated the adverse effects in vivo inhalation exposure of ultra fine
silver compounds. Silver shows potential to be toxic due to its strong affinity with –SH
groups (Hussain et al., 1994). Braydich et al. (2005) found silver to be toxic in germ line
stem cells (Braydich-Stolle et al., 2005). The mechanism of toxicity has yet to be fully
investigated, although it is believed to be mediated by oxidative stress (Hussain et al.,
2005). Nano-sized silver and other compounds can also be considered a threat to human
health because of their ability to rapidly and easily translocate to the blood. The barrier
between the alveolar wall and capillaries is only 500nm thick (Hoet et al., 2004).
There is a lack of information on the basic toxicity of nano-size silver, including
their biological interactions with cells and further, their interaction with cellular proteins.
The major toxicological concern is derived from the fact that some of the manufactured
nanomaterials are redox active (Beck-Speier et al., 2005), and some particles cross the
cell membranes, especially into the mitochondria (Foley et al., 2002). The recent study by
Oberdorster (2004) indicated that nanomaterials (Fullerenes C60) induced oxidative stress
in a fish model.
Normal concentrations of silver in human tissues are very low. The most
common health effect associated with prolonged exposure, typically dermal, is argyria.
Argyria results in a permanent bluish-gray discoloration of the skin and with an enhanced
effect on areas routinely exposed to light (i.e. arms and face) (Drake and Hazelwood,
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2005). . Current OSHA and NIOSH standards limit exposure of silver compounds
(including solubles, metal dusts and fumes) to 0.01mg/m3. The limit is intended to
reduce the occurrence of argyria in the occupational setting. Another common health
effect of workers exposed to silver dust and particulates is upper and lower respiratory
infections. Overall, the toxicity of silver depends heavily on the form. For example,
liquid silver nitrates and chlorides are found to be extremely toxic, but oxides are not.
Drake et al. (2005) also report that exposure to large amounts of silver iodide does not
lead to argyria. In contrast, chronic exposure to silver chloride and nitrate dusts does lead
to respiratory infection and abdominal pain (Rosenman et al., 1979).
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PURPOSE
In this study, the toxic effects of silver nanoparticles (hydrocarbon-coated Ag-15,
30 and 55nm) will be investigated (Fig. 3). The toxicity end points (MTT and LDH)
represent mitochondrial function and membrane integrity, vital implications of cell
viability (Castell et al., 1997; Oberdorster et al., 2005b). It is also postulated that the
mechanism of toxicity is due to oxidative stress (Beck-Speier et al., 2005; Brown et al.,
2001; Li et al., 2003). Therefore, an assay quantifying reactive oxygen species
generation (ROS) will be conducted to investigate this theory. Alternatively, it is
suggested that nanoparticles induce an “overload” effect on the macrophages,
subsequently reducing/inhibiting their ability to function properly (Lundborg et al.,
2001). Although the exact mechanism will not be revealed during this study, data will
provide support the future efforts in this arena.
Nanomaterials have had a great impact on science and technology over the last
years, to include applications in sunscreens, paints, optical and electrical applications,
anti-bacterial agents (Ag) and as rocket-fuel additives (Al). With increasing applications
and popularity comes an increase in manufacturing and production. The basis of this
study stems from the lack of information regarding the occupational risks, hazards and
health implications
The purpose of this in vitro study is to determine the relative toxicity of various
nano-sized silver particles in rat alveolar macrophages. The results of this study will (1)
characterize the cytotoxicity of varied nanoparticles (via calculation of EC50 values), (2)
investigate the mechanism of toxicity of carbon-coated silver (Ag-15, 30, 55nm)
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nanoparticles and (3) provide valuable data for future use in risk assessment and
prediction of health effects due to exposure.
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Figure 3: Schematic diagram summarizing study outline.
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HYPOTHESIS
Nanoparticles have a wide range of daily applications and their size makes them
small enough to be inhaled during exposure, reaching the deep region of the lung
(alveoli). Although the toxicity of fine heavy metals in the µm range (fine) has been
determined (Donaldson et al., 2000; Donaldson et al., 2001; Donaldson et al., 2002), the
toxicity of heavy metal nano-sized (ultra fine) materials is not known. Based on this
information, the hypothesis is that acute exposure to silver nanoparticles affects rat
alveolar macrophages, leading to morphological changes, affects on mitochondrial
function and membrane integrity and lead to cytotoxicity through the generation of
reactive oxygen species.

Specific Aims
(1) Optimize technique for nanoparticle delivery to cells using various aqueous
solutions and mixing methods
(2) Test the hypothesis that nanoparticles are taken up into the cells and induce
morphological changes in macrophages using CytoViva URI system and light
microscopy.
(3) Test the hypothesis that mitochondrial function and membrane integrity are
compromised and cell viability is reduced following exposure to silver
nanoparticles, using MTT and LDH assays.
(4) Test the hypothesis that heavy metal nanoparticles induce oxidative stress by
quantifying ROS generation following exposures.
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EXPERIMENTAL APPROACH
Chemicals and Reagents
Hydrocarbon-coated silver (15, 30, 55nm) and uncoated silver (130nm) were
generously received from Dr. Karl Martin, Nanotechnologies, Inc. (Austin, TX). Rat
alveolar macrophages (NR8383, CRL-2192), Ham’s Nutrient Mixture F-12K (Kaughn’s
Modification) and normal fetal bovine serum (FBS) were purchased from ATCC
(Manassas, VA). Penicillin-streptomycin and 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT) were purchased from Sigma Chemical Company
(St. Louis, MO). Phosphate buffered saline, 10x, (pH 7.4) and 2.5% trypsin were
purchased from Gibco Invitrogen™ Corporation (Carlsbad, CA). Rat tail collagen (type
1) from UPSTATE (Waltham, MA). Dichlorofluorescin diacetate (DCFH-DA) from
Molecular Probes™ (Carlsbad, CA). CytoTox-ONE™ Homogeneous Membrane
Integrity Assay was purchased from Promega. Cadmium oxide (CdO-1000nm) was
purchased from Fluka Chemicals. Immunopure horseradish peroxidase (HRP) was
purchased from Pierce chemical.
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Cell Culture Techniques
Rat alveolar macrophages (AM) received from ATCC (CRL-2192) served as a
model for inhalation exposure. Macrophages were grown in Ham’s Nutrient Mixture F12K (Kaughn’s Modification), pH 7.3, with 20% FBS and 1% antibiotic
penicillin/streptomycin mixture. During exposure, FBS concentration was reduced to
10%. Media with reduced serum is referred to as “exposure media.” Cells were used
between passages 5 to 55.
Cells were seeded or grown on rat tail type 1 collagen-coated flasks, 6, 12 or 96
well plates or chamber slides and maintained in a 5% CO2, water-jacketed incubator at
37°C. Flasks and plates were coated with collagen for adhesion. AM’s grow naturally as
a floating suspension, with slight adhesion.
All cell culturing was conducted under a biological hood. Cells were detached
from the flasks by an enzymatic mechanism. Once highly confluent, media was removed
and 1.5 ml of 0.25% trypsin was added to each flask and incubated at 37°C for 2-3
minutes. Cells were then resuspended by repeatedly washing the bottom of the flask with
5 ml of media. A volume of 1.5 ml of cell suspension was then added to the new flasks
with 12.5 – 15.0 ml media. A cell count was then performed on the remaining cell
suspension used for seeding. After seeding or splitting of new cells (6 h), cells were
washed 1-2x with PBS and replaced with fresh media. Following the initial seeding, old
media was replaced with new media every 48 hours.
A brief cell proliferation study was conducted to assess the growth rate of cells when
seeded at various densities. Cell densities of 150k, 250k, 350k and 500k were seeded in
6 and 12 well plates. Each day, cells were extracted from a new well and viable cells
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were counted using trypan blue. After 48 hours, fresh media was exchanged with old
media. Growth was assessed for 96 hours.
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Dispersion Tests
Nanoparticles are manufactured as a powder/solid state and need to be delivered
to the cells in exposure media. Dispersion tests were conducted in physiological
phosphate buffered saline (PBS, pH 7.4), deionized water (dI H2O), dimethylsulfoxide
(DMSO) and 200 proof ethanol (EtOH). Dispersion was observed following initial
suspension and after vigorous mixing with a touch vortexer or brief probe sonication (510 seconds, 60 Watts). Sonication utilizes sound wave energy (ultrasonics) to “break up”
the materials. Digital images were captured as well as comments regarding physical
characteristics, changes, settling, etc. 10 mg/ml stock solutions were then prepared based
on the success of the dispersion and mixing tests. From this stock solution, various
concentrations (0-250 µg/ml) of Ag-NP were prepared in exposure media for testing.
Changes in pH and turbidity were recorded following the suspension of these
“dosing solutions.” Both turbidity and pH are key cell culture constituents. It is
postulated that turbidity, the degree of cloudiness in solution, can lead to toxicity by
inhibiting respiration of the cells. A pH range of 7.2 to 7.4 provides the optimal
environment for cell proliferation, although some cells are capable of growing at
extremes from 7.0 to 7.6. (Barile, 1994)
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Treatment protocol
For all experiments, cells were seeded at a specific density (250 – 500 x 103 cells/ml)
in 6 or 96 well plates or chamber slides and grown for 48-72 hours as seem in figure 4.
Upon reaching ~80% confluency, cells were washed 1x with PBS. Dosing media (1.0
ml) containing Ag-NP in the range of 0-100 µg/ml was then added directly to each well
and cells were returned to incubator for the exposure interval (24h). At the end of the
exposure period, toxicity end points were evaluated in control and nanoparticle-exposed
cells.
CdO (0-25 µg/mL) was used as a positive control in MTT and LDH assays due to
its ability to cause significant (p<0.05) decreases in mitochondrial function and cell
viability at a low dose (0.5 µg/ml).
AgNO3 was also used to compare the toxicity of Ag-NP to that of a bulk, soluble
silver compound. Dosing solutions of both CdO and AgNO3 were prepared in the same
manner as Ag-NP.
Serial dilutions of hydrogen peroxide, derived from 30% H2O2, were used to
create a standard curve for ROS assays.
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Figure 4: Treatment protocol. Cells were seeded in 6 or 96 well plates, then
allowed to reach ~80% confluency. Upon reaching confluency, AM’s were treated
with appropriate NP doses. MTT, LDH or ROS assays were then conducted at the
end of the 24h timepoint.
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Nanoparticle Characterization
Powdered nanosilver samples were analyzed for size and surface area and were
imaged with transmission electron microscopy (TEM) by Maria Palazuelos and Dr.
Kevin Powers of the Particle Engineering Research Center, University of Florida. As
previously described, Ag-15, 30 and 55 nm particles are coated with a hydrocarbon
matrix for dispersion and stability. For the purpose of this characterization study, Ag-NP
were washed of their coating. A 10 mg/ml suspension in 200 proof ethanol was prepared
for each size and allowed to dry under UV light overnight. The Ag-NP were then
resuspended in 10.0 ml sterile, dI H2O and centrifuged (12,500 rpm) for 10 minutes. The
supernatant was removed and the particles were washed with sterile dI H2O. This
washing step was completed three times. Following the last washing, NP were
resuspended in 10.0 ml of dI H2O and the final concentration was determined by drying
1.0 ml of the solution. Brunauer, Emmet, Teller (BET) analysis was conducted using a
Quantichrome Autosorb IC-MS to measure surface area from gas adsorption. The
following equation was used to calculate the mean diameter from the specific surface
area (SSA) measured:
d = __ 6___
SSA * ρa
Where d = diameter
SSA = specific surface area / unit mass (m2/g)
ρa = true density (10.49 kg/m3)
Next, TEM was used to assess the size, shape and thickness of carbon coating of
unwashed Ag-NP. Samples were prepared by dispersion in 200 proof ethanol and brief
sonication in a bath sonicator for 30 seconds (2kHz and 135 sonic watts). A drop of the
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suspension was placed on a carbon-silicon grid. Samples were left to dry and analyzed in
a JOEL TEM 2010F.
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Morphology
For microscopy studies, alveolar macrophages were grown to 80% confluency and
exposed under the same conditions as described in Treatment Protocol. After 24 hours of
exposure, excess media was removed via aspiration and the cells were washed 1-2x with
PBS before preparing slides. Note: Cells observed at 20x were grown and remained in 6well plates. Cells observed at higher magnification (100x, oil) were grown in dualchamber slides.
Qualitative morphological changes
Rat alveolar macrophages were treated as mentioned above with various
concentrations of Ag-NP for 24 h. After completion of the exposure period, cells (control
and exposed) were washed 1-2x with PBS and observed by an inverted light microscope
(Olympus CK2) at 20x and 100x (oil) magnification. Images were captured via
QCapture Pro Imaging Software.
Interaction of nanomaterials
Macrophages were seeded in dual-chamber, collagen coated slides for 6h then dosed
with 25 µg/ml Ag-NP suspended in exposure media. Following the 6h exposure period,
cells were washed 1-2x with PBS and covered with a glass cover slip. Prepared slides
were then inverted and observed with an Olympus IX71 Microscope platform coupled to
the CytoViva™150 Ultra Resolution Imaging (URI) System at 60x (oil) magnification.
Cell morphology was initially observed, followed by uptake of nanoparticles. Images
were captured via QCapture Pro Imaging Software and stored with Microsoft PowerPoint
and Microsoft Picture Manager.
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Mitochondrial function
Mitochondrial function was evaluated spectrophotometrically by utilizing a
colorimetric assay which measures the degree of mitochondrial reduction of the
tetrazolium salt 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) to
(aqueous insoluble product) formazan by succinate dehydrogenase (Carmichael et al.,
1987). Following exposure, 250 µl of 10x MTT was added directly to each well. Cells
were then incubated for 20-30 minutes to allow appropriate time for reduction/formation
of color. Viable cells with functioning mitochondria were able to reduce the MTT salt
(yellow) to formazan, leaving a blue color (Fig. 5). The formation of this blue color
marked the end of incubation time and the color was extracted with acidified isopropyl
acid (IPA). Samples were transferred, in duplicate, to a 96 well plate and the optical
density (OD) of the extract was assayed with a SpectraMAX Plus 190 microplate reader
at 570 nm wavelength and subtracted from 530 nm wavelength (Molecular Devices,
Sunnyvale, CA). Each experiment was conducted in triplicate and data are reported as a
percent of control.

Percent of MTT reduction was calculated as follows:
%MTT = 100 * (ODt/ODc)
Where %MTT = % Reduction of MTT function
ODt = Optical density of treated cells
ODc= Optical density of control cells
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MTT

Formazan
Succinate
dehydrogenase

http://micro.magnet.fsu.edu/cells/mitochondria/images/mitochondriafigure1.jpg

Figure 5: Diagram of colorimetric MTT assay. Succinate dehydrogenase, an
enzyme produced in the matrix of the mitochondria is necessary to reduce the
yellow MTT salt to a blue formazan. Color is extracted and OD is measured by an
absorbance spectrometer in order to calculate the % of functioning mitochondrial
compared to control (untreated) cells.
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Membrane Integrity
Membrane damage that results in LDH leakage is generally considered an
irreversible cytotoxic event; therefore, LDH leakage was used as a biomarker of cellular
viability. Membrane integrity was assessed by measuring extracellular lactate
dehydrogenase (LDH) according to the procedures described in the CytoTox-ONE™
Homogenous Membrane Integrity Assay kit (Fig. 6). The kit provides a homogeneous,
fluorometric method for measuring non-viable cells present based on the release of LDH.
Fluorescence was measured at an excitation and emission wavelength of 560nm and 590
nm with the SpectraMAX Gemini Plus (Molecular Devices, Sunnyvale, CA) fluorescent
microplate reader. The kit also allows for quantification of viable cells in that the
fluorescence values are directly proportional to the number of viable cells. Data are
reported as a percent of control.
% Cytotoxicity = 100 * ((Treated – Background)/(Control – Background))
Three controls were performed with each assay; a no-cell control, untreated cells
control and a maximum LDH release control in which 100% of cells are lysed.
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Figure 6: Diagram of fluorescent LDH assay. Release of LDH from damaged
cells is measured by supplying lactate, NAD+ and resazurin as substrates in the
presence of diaphorase. Fluorescent resofurin product is proportional to the
amount of LDH (Promega #TB306).
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Oxidative stress
The generation of intracellular reactive oxygen species (ROS) was determined
using dichlorofluorescin diacetate (DCFH-DA) (Wang and Joseph, 1999), with minor
modifications as previously described by Hussain and Frazier (2002). As described in
figure 7, DCFH-DA is hydrolyzed by intracellular esterases to dichlorofluorescin
(DCFH) . In the presence of cellular oxidants, this non-fluorescent DCFH is further
oxidized to fluorescent dichlorofluorescin (DCF).
Cells were seeded in black 96 well plates 24h before exposure. Cells were treated
and handled in a light controlled environment throughout the assay. Prior to treatment,
growth media was aspirated and replaced with media containing 100 µM DCFH-DA and
incubated for 20-30 min. under normal cell culture conditions. The DCFH-DA probe
was then removed, cells were washed 1x with PBS and treated with dosing solutions.
The plate(s) were then placed back in the incubator and assayed after 24h. Fluorescent
values of control and exposed cells were measured at an excitation wavelength of 485 nm
and an emission wavelength of 530 nm in the 96-well plate using the SpectraMAX
Gemini Plus (Molecular Devices, Sunnyvale, CA) fluorescent microplate reader. Data
are reported as a fold of increase compared to control. A standard curve of H2O2
concentrations was assayed in conjunction with treated cells.
Nanoparticle-associated ROS was also assayed to confirm intracellular ROS
generation. Because the DCFH-DA reaction follows a specific pathway, a cell free
system utilizing Immunopure HRP was used to mimic the cellular conditions. 10mM
DCFH-DA in DMSO (50 µl) was mixed with 2 ml of 0.01 N sodium hydroxide. The
hydrolyzate was allowed to stand at room temperature for 30 minutes and then
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neutralized with 10ml sodium phosphate buffer (pH 7.2). The solution was kept on ice
and in the dark until use. Prior to assay, the 42 µM DCFH was mixed with HRP in a
ratio such that the working reagent of DCFH-HRP contained 2.2 units of HRP/ml
reagent. To assay nanoparticle associated ROS, the appropriate volume of NP stock
solution was added to a tube, mixed well and allowed to sit for ~30-60 minutes. At this
point, 200 µl of each sample was transferred to a 96-well plate and read on fluorescent
plate reader. Blanks were measured and subtracted from each sample.
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Figure 7: Diagram of fluorescent ROS assay. In the presence of cellular esterase,
DCFH-DA is reduced to a non-fluorescent DCFH. If ROS are released, DCFH is
then oxidized to fluorescent DCF. Fluorescent intensity is then measured and data
are reported as a fold increase in ROS generation compared to control groups.
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Statistical Evaluation
The data were expressed as mean ± standard deviation (SD) of three
independent experiments. Wherever appropriate, the data were subjected to statistical
analysis by one-way analysis of variance (ANOVA) followed by Tukey-Kramer’s
procedure for multiple comparisons. A value of p < 0.05 was considered significant.
pHStat Excel add-in, SigmaStat for Windows version 2.03 and SigmaPlot software were
used for the statistical analysis.

33

RESULTS
Dispersion tests
Due to the fact that nanoparticles, specifically non-polar compounds, tend to
agglomerate and settle rapidly when added to aqueous solution, initial dispersion tests
were conducted in physiological phosphate buffer saline (PBS; pH 7.4), deionized water,
dimethyl sulfoxide (DMSO) and ethanol (EtOH) to examine the behavior of the particles
in various solutions. DMSO produced the greatest homogeneity followed by ethanol,
water and PBS. In most cases, when added to PBS, silver (30, 55nm) precipitated and
since DMSO and ethanol are relatively toxic themselves, they were excluded as
candidates for stock solution preparation (Fig. 8). The smaller Ag-NP (15 and 30) mixed
well with just vortexing. However, the larger Ag-NP (55 and 130) did not appear to
disperse well in any solution and required more extensive mixing. It was found that the
best physical mixing method was brief sonication with a probe sonicator at 60W (5-10
seconds) to produce an even suspension of the initial solution, followed by constant
vortexing. Based on the success of the homogeneous dispersion studies using physical
mixing, stock solutions of Ag-15, 30, 55 and 130 nm particles were suspended in deionized water. From this stock solution, final concentrations were prepared in cell
growth medium Ham’s Nutrient Mixture F-12K (Fig. 9).
It was also noted that turbidity appeared to increase with increasing concentration
of nanomaterials. Figure 10 shows NP in media at concentrations of 0, 5, 10, 25, 50 100
and 250 µg/ml. Although absorbance was not measured to determine the specific degree
of turbidity, it is obvious that Ag-15 and 30nm at high doses (>50 µg/ml) produced a
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“cloudier” solution than at lower concentrations. In view of their turbidity, the highest
dose was limited to100 µg/ml.
In conjunction with the dispersion tests, a few tests were conducted to optimize
treatment techniques. A short cell proliferation study was conducted in which various
densities were seeded in different well sizes to determine the optimal seeding density. It
was found that cells seeded at 350 and 500 x 103 cells/ml resulted in the best growth rate
with 0.9 mil and 1.1 mil after 48h. The reduction of FBS in “exposure media” was also
investigated prior to experiments. Various concentrations (20, 10 and 5%) of FBS were
tested for cell proliferation and 10% was found to be the optimal concentration for
maintaining cell count without a large growth rate. It is important to maintain cell
viability and not promote growth with excess serum so that the control cells can still be
compared to the treated cells.
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Ag-15nm Dispersion Test

Before Vortex

B

After Vortex

Ag30nm Dispersion Test

Before Vortex

C

After Vortex

Ag-55nm Dispersion Test

Before Vortex

D

After Vortex

Ag-130nm Dispersion Test

After Vortex

Before Vortex

Figure 8: Digital images of NP in four different aqueous solutions (PBS, dI
water, DMSO and EtOH) before and after mixing with vortexer for 15-20 seconds.
(A) Ag-15nm (B) Ag-30nm (C) Ag-55nm (D) Ag-130nm.
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Figure 9: Dosing solution preparation protocol. Nanopowder is suspended in dI
H2O at 10 mg/ml, briefly sonicated, then aliquots are added to exposure media to
make dosing solutions. After vigorous mixing, dosing solutions are then added
directly to wells containing AM’s and allowed to incubate for 24h.
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A
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Figure 10: Digital images of the turbidity of NP in dosing media. From left to
right, concentrations are 0, 5, 10, 25, 50, 100 and 250 µg/ml. (A) Ag-15nm (B)
Ag-30nm (C) Ag-55nm (D) Ag-130nm.
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Nanoparticle Characterization
Brunauer, Emmet, Teller (BET) analysis reveals that nanoparticles, particularly
Ag-55 and 130nm, are larger in diameter than reported by Nanotechnologies, Inc. Table
2 summarizes the results from SSA analysis/comparison, indicating that Ag-15nm is
actually ~ 19nm, Ag-30nm is ~53nm and Ag-55nm is ~119nm. Results were calculated
based on the given true density (10.49 kg/m3) and data from specific surface area
analysis. However, it should be noted that for BET analysis, samples were washed of
their coating and underwent a different preparation method that could have altered the
diameter that was measured by increasing agglomeration.
All samples were found to be polydispersed in diameter. Particle size distribution
data has yet to be confirmed, but it is has been reported that the mean size distribution is
in close proximity to the reported size.
The carbon coating is apparent in the TEM images (Fig. 11). These high
resolution images also show lattice distribution of atoms for each sample. Images at a
lower magnification show that the NP tends to agglomerate, but the actual diameter of
agglomerates has yet to be determined.
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Particle Characterization
as determined by the Particle Engineering Research Center, Univ. of Florida
Chemical
Ag
Ag
Ag
Ag

Size
(nm)
15
30
55
130

Manufacturer
Nanotechnologies, Inc.
Nanotechnologies, Inc
Nanotechnologies, Inc
Nanotechnologies, Inc

SSA
(m2/g)
33.95
10.63
4.79
n/a

Diameter
(nm)
17
53
119
n/a

Table 2: BET analysis was conducted to determine actual diameter of
manufactured NP from Nanotechnologies, Inc. SSA reveals the diameters of Ag30 and 55 are larger than reported.
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Figure 11: TEM images of silver nanoparticles. (A-B) Ag-15nm, (C-D) Ag30nm and (E-F) Ag-55nm. The hydrocarbon-coating can be seen “surrounding”
NP. Note: TEM images show lattice distribution of atoms.
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MTT Assay
Figure 13 shows the effect of silver nanoparticles on the mitochondria of rat
alveolar macrophages. The results of the MTT assay reveal significant decreases in
mitochondrial function in rat alveolar macrophages when exposed to Ag-15 (F5, 10 = 69.3,
p<0.001), Ag-30 (F6, 12 = 70.7, p<0.001), Ag-55 (F6, 6 = 12.24, p<0.01) for 24h from 1075 µg/ml. CdO (1000nm) served as a positive control due to its ability to significantly
(F6, 6 = 94.5, p < 0.001) reduce mitochondrial function at extremely low doses (0.5 µg/ml)
(Fig. 12). When compared to untreated control cells, exposure to Ag-15 and 30nm in
particular, resulted in significant decreases in mitochondrial function. At the highest dose
for Ag-15 nm, 24h exposure to 50 µg/ml resulted in an 88.7 ± 1.8% decrease. Similarly,
24h exposure to 50 and 75 µg/ml Ag-30 nm resulted in a 69.7 ± 7.9 and 91.2 ± 1.4%
decrease in mitochondrial function, respectively. Compared to the smaller nanoparticles
(15 and 30 nm) Ag-55 nm did not exhibit significant toxicity until 50 to 75 µg/ml, with
only a 33.9 ± 7.9% (F6, 6 =12.2, p < 0.01) decrease at the highest dose. Although
“statistically significant,” data show the effect of Ag-130 nm (F6, 12 = 6.97, p<0.01) on rat
AM’s mitochondrial function was minimal. At the highest dose, 100 µg/ml,
mitochondrial function was decreased by 23.3 ± 6.1%.
To compare the effects of metallic silver nanoparticles to a bulk, soluble silver
compound, AgNO3 was assayed and data reveal similar toxic effects on mitochondrial
function compared to Ag-15 nm. At 50 µg/ml AgNO3, 98.7 ± 0.5% (F5, 10 = 25.3, p <
0.001) of exposed AM were non-viable based on the lack of ability for the mitochondria
to reduce the MTT salt.
EC50 values for a 24h exposure, which represent the concentration of Ag-NP that
will reduce mitochondrial function by 50%, were calculated and found to be 27.9 ±12.2
and 33.4 ± 11.5 for the smaller nanoparticles, Ag-15 and Ag-30nm (Table 3). Because
Ag-55 and 130nm failed to reduce mitochondrial function by at least 50% at their highest
doses, 75 and 100 µg/ml, respectively, an exact EC50 value could not be calculated.
Therefore, EC50 values for the larger nanoparticles are represented simply as >75 µg/ml.
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Figure 12: Effect of CdO on mitochondrial function (MTT assay). CdO is shown
to be significantly toxic at low doses (5 µg/ml); therefore is used as a positive
control and assayed in conjunction with Ag-NP. Data are expressed as a mean of
three individual experiments, conducted in triplicate. (*) indicates a statistically
significant difference compared to control (p<0.05).
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Figure 13: Effect of silver nanoparticles on mitochondrial function (MTT assay).
Results represent percent of MTT reduced compared to control. Data indicate Ag15 and 30nm are toxic at low doses (5 and 10 µg/ml Ag15nm, respectively) and
Ag55nm does not significantly reduce mitochondrial function until higher doses
(50 µg/ml). Data are expressed as mean ± SD of three independent experiments,
conducted in triplicate. (*) indicates a statistically significant difference compared
to control (p<0.05).
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MTT

LDH

Chemical
Ag 15nm

EC50
(µg/ml)
27.87 ± 12.23

EC50
(µg/ml)
14.75 ± 1.63

Ag 30nm

33.38 ± 11.48

13.89 ± 0.82

Ag-55nm

>75

>75

Ag-130nm

>75

>75

AgNO3

27.38 ± 11.39

---

CdO

0.42 ± 0.13

4.27 ± 6.26

Table 3: Calculated EC50 values of silver nanoparticles, AgNO3 and CdO: EC50
values represent the effective concentration of compound required to decrease
MTT reduction by 50% and increase LDH leakage by 50%. Data are expressed as
mean ± SD of three independent experiments, conducted in triplicate. (*) indicates
a statistically significant difference compared to control (p<0.05).
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LDH Assay
Membrane integrity of control and treated cells following a 24h exposure was
evaluated by measuring LDH activity. Since LDH is not typically found extracellularly
around normal, healthy cells, extracellular measures of LDH were used as an indicator of
membrane damage and cell viability. As indicated in figure 14 exposure to Ag
nanoparticles for 24h resulted in a size and dose-dependent decrease in cell viability
compared to control cells (0 µg/ml). Similar to the MTT results, Ag-15 nm and Ag-30
nm exhibited significant (F6, 12 = 29.1, p < 0.001 and F6, 12 = 24.3, p < 0.001, respectively)
cytotoxicity at 10-75 µg/ml, while Ag-55 and 130nm required higher doses (>50 µg/ml)
to significantly decrease cell viability.
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Figure 14: Effect of silver nanoparticles on membrane integrity (LDH assay).
Results represent percent of LDH leakage compared to control; indicative of
membrane damage. Ag-15 and 30nm show similar results, with significant
leakage at low doses. Similar to MTT data, Ag55nm is shown not to be toxic until
high doses. Data are expressed as mean ± SD of three independent experiments,
conducted in triplicate. (*) indicates a statistically significant difference compared
to control (p<0.05).

47

ROS Assay
As a standard calibration curve, various concentrations of H2O2 were assayed for
ROS generation. Figure 15b illustrates the concentration-dependent response of cells
exposed to H2O2. H2O2 concentrations in the range of 0 to 1000 µM were linearly
correlated (r = 0.9905)
Particle-associated ROS was also measured using a cell-free environment to verify
ROS generation was intracellular and not due to interaction with Ag-NP. Results found
an insignificant generation of ROS (<1.2 fold increase) when evaluating nanoparticles
(data not shown).
ROS generation following 24 h of exposure to silver nanoparticles and AgNO3 are
shown in figure 15a. Ag-15nm exhibited the greatest response with a 7.32±1.24 (F6, 12 =
5.7, p < 0.01) and 15.16±5.77 (F6, 12 = 5.03, p < 0.05)-fold increase at 25 and 50 µg/ml
compared to control cells. Interestingly, Ag-55nm did show the second highest increase
in ROS generation with a 4.60±0.51 (F6, 12 = 23.2, p < 0.001) increase at 75 µg/ml. Ag30 and 130nm produced a less than three-fold increase at the highest dose.
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Figure 15: (A) Generation of reactive oxygen species following exposure to
silver nanoparticles (ROS assay). (B) Standard curve of ROS generation vs.
H2O2. Data are expressed as mean ± SD of three independent experiments,
conducted in triplicate. (*) indicates a statistically significant difference compared
to control (p<0.05).

49

Morphology
As an initial assessment of general toxicity, images of untreated and treated cells
(24h) were captured at 20x magnification with a light microscope (Fig. 16). Images are
expected to give a general degree of toxicity. If cells appear normal and healthy
compared to controls, the compound is not thought to be toxic. However, if visible
damage to the membrane or other cellular components is apparent, it is expected that
MTT and LDH data should have corresponding decreases.
Control and cells treated with 10 and 75 µg/ml are represented for Ag-15, 30 and
130nm. Note that cells appear to be abundant and of normal size and shape in control
images (A-B). Following exposure, at the higher dose, the number of cells appears to
have decreased, with visual cell debris (likely dead cells). Also, agglomerates of NP are
clearly seen in cells treated at high doses of Ag-15, 30 and 55nm (D, F, H) and at the
lowest dose for Ag-55nm (G). In the images of all treated cells, it can be seen that the
macrophages are surrounding the NP and are either attached to the membrane or
internalized.
Images captured via phase contrast inverted microscope at 100x, oil magnification
indicate cellular damage when compared to control as depicted in (Fig. 17). Control cells
(A-D) are shown as healthy and relatively symmetrical in size and shape. Following
treatment with Ag-15 nm at 25 and 75 µg/ml, cells appear to lack a defined membrane
and indicate damage with cell debris floating in the media (E-L). Nanoparticles are also
shown associated with the membrane or internalized (cannot be determined from
images). Cells exposed to Ag-30nm at 25 and 75 µg/ml, show similar results as Ag15nm, supporting the MTT and LDH data (M-T). However, nanoparticles are also shown
to be more agglomerated in certain places of the cultured plates with cells in Ag-30nm
dosing solutions (M, N, R). Nanoparticles are also seen attached or internalized by
macrophages (N-T). As the toxicity data indicates a decreased toxicity from Ag-55nm,
images support the lack of effect on the macrophages following exposure (U-BB). Large
agglomerates of nanoparticles were also observed, as seen in V, W, Z, and AA.
Compared to control and Ag-15 and 30nm exposed cells, AM’s treated with Ag-55nm
did not appear to effect cell morphology. At the higher dose of Ag-55nm (75 µg/ml),
nanoparticles are seen attached or internalized (Y, Z and BB).
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To investigate the interaction of NP with AM’s, images were captured with a
CytoViva Ultra High Resonance Imaging system (Fig. 18). Images show control cells
and cells treated with 25 µg/ml of Ag-15 (C), Ag-30 (D), Ag-55 (E) and Ag-130 (F) for
6h. It is assumed that he bright regions indication NP. Based on this assumption, it is
clear that the NP are internalized and/or attach to the membrane. Exposure to Ag-130nm
(F) shows an aggregate of NP attached to the membrane and a clear lack of
internalization. Although images show internalization of NP, in aggregate and nonaggregate form, it is not known whether the nanoparticles are taken up prior to
agglomeration or agglomerate following uptake.
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Figure 16: Morphological images captured via phase contrast light microscope at
20x magnifications following a 24h exposure:
(A-B) control cells
(F) 75 µg/ml Ag-30nm
(C) 10 µg/ml Ag-15nm
(G) 10 µg/ml Ag-55nm
(D) 75 µg/ml Ag-15nm
(H) 75 µg/ml Ag-55nm
(E) 10 µg/ml Ag-30nm
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Figure 17: Morphological images captured via phase contrast light microscope at
100x (oil) magnification following a 24h exposure:
(A-D) control cells
(Q-T) 75 µg/ml Ag-30nm
(E-H) 25 µg/ml Ag-15nm
(U-X) 25 µg/ml Ag-55nm
(I-L) 75 µg/ml Ag-15nm
(Y-BB) 75 µg/ml Ag-55nm
(M-P) 25 µg/ml Ag-30nm
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Figure 18: CytoViva URI images at 60x magnification after 6h at 25 µg/ml of
each Ag-NP. Bright spots are assumed to be nanoparticles either internalized or
attached to membrane.
(A-B) control cells. (C) Ag-15nm (D) Ag-30nm (E) Ag-55nm (F) Ag-130nm.
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DISCUSSION
As far as the assessment of toxicological properties of nanoparticles is concerned,
it is not known how they behave when they are dispersed in exposure media. The other
issue that is still not known is whether the cells take up nanoparticles, and if so, what
mechanisms are involved. Our microscopy results showed that nanoparticles associate
with cell membranes and that the cells take up some of the particles. It is believed the
nanoparticles associated with the cell membrane or entering the cells are likely to have an
effect on cellular function. Further, surface area, dimension, surface energy may be
important factors that account for toxicity. The present study aimed to investigate the
general toxicity and interaction of silver nanoparticles with rat alveolar macrophages. Of
particular concern are the effects of occupational exposure during the manufacturing and
handling process. Their nano-size makes them unique and alters their behavior when
compared to its origin of materials. In medical applications, silver is currently used for
the treatment of burn and chronic wounds, with new products containing nano-size silver
currently being developed and introduced commercially. Other potential applications
include antimicrobial/antiviral coatings, paints, creams, lotions, fabrics, etc, for medical,
industrial and consumer markets. Silver nanoparticles have received considerable
attention due to their attractive physicochemical properties when compared to different
novel metal nanomaterials. The strong toxicity that silver exhibits in various chemical
forms to a wide range of microorganisms is very well known (Liau et al., 1997;
Nomiya et al., 2004) and silver nanoparticles have recently been shown to be a
promising antimicrobial material (Sondi and Salopek-Sondi, 2004).
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Before implementing the various applications of silver nanoparticles, it is
necessary to investigate the potential toxicological impacts of silver nanomaterials. It is
known historically that silver produces a critical effect in humans who have ingested
silver. This condition is argyria, a medically benign but permanent bluish-gray
discoloration of the skin. It is unclear how nanosilver interacts and instigates toxicity in
mammalian cells. However, there are some reports on nano-size silver on bacteria and
viruses. A recent study illustrated nanosilver’s potentially huge impact on the fight of
AIDS (Elechiguerra et al., 2005); demonstrating the ability of nanosilver (1-10 nm range)
to attack HIV-1, preventing interaction of the virus with host cells. In addition, silver
nanoparticles were found to be completely cytotoxic to E. coli for surface concentrations
as low as 8 µg of Ag/cm2 (Baker et al., 2005).
There are limited studies available investigating the toxic effects of nanomaterials
and no clear guidelines are available to quantify these effects. Recently, Lam et al. (2004)
reported that nanotubes induced lung tissue damage in mice resulting in granulomas.
Another report by Warheit et al. (2004) investigated acute lung toxicity and observed that
intra-tracheally instilled single-wall carbon nanotubes produced granulomas in rats at
very high doses (Warheit et al., 2004). Although, in vitro data is not a substitute for
whole animal studies, use of simple in vitro models with end points that reveal a general
mechanism of toxicity can be a basis for further assessing the potential risk of
chemical/material exposure.
In this study, it was found that nanosilver exhibited toxicity in rat AM’s in a sizeand concentration-dependent manner. The main function of AM’s is to engulf foreign
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matter and clear it from the lungs. By showing the toxic effects of NP on the AM’s, the
potential for long-term damage is reinforced.
Because this type of research is relatively new, there are not many clear
guidelines or solid references to call upon, forcing each assay to be modified and
customized for nanoparticles. Further, very few in vitro studies have been conducted as a
model of toxicity. For example, it is not known how NP behave when dispersed in
media. Dispersion tests and a dose range study were initially conducted to determine the
basic parameters. It was found that, although not a perfect homogenous solution for the
larger NP (Ag-55 and 130 nm), deionized water provided the best aqueous solution for
dispersion. For the most part, the larger NP quickly settled out of solution, requiring
vigorous, constant mixing with a vortexer during preparation of stock solutions, dosing
solutions and during the treatment phase. Also, based on general observations of dosing
solutions, turbidity tended to increase as concentration increased. Although the exact
absorbance values were not measured, there were clearly increases in the degree of
cloudiness by visual reference. A single MTT assay was also conducted to determine an
appropriate dose range by testing varying concentrations in the range of 0-250 µg/ml. It
was found that Ag-NP had extensive (> 98%) toxicity beyond 100 µg/ml when exposed
to the smaller sizes of Ag-NP. Based on the success of these initial tests, an appropriate
preparation method and dose range was developed, serving as a base for the experiments.
Further, it is not known whether the cells take up the nanoparticles, and if so, by
which mechanism. Images captured by both light microscopy at 100x magnification and
by the CytoViva URI system show what is believed to be Ag-NP agglomerates inside the
cell after 6h. Although images show internalization of NP, in aggregate and non-
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aggregate form, it is not known whether the nanoparticles are taken up prior to
agglomeration or agglomerate following uptake. Exposure time was limited to 6h due to
the fact that the Ag-NP were too toxic after 24h, leaving very few undamaged cells for
assessment. As a general toxicity evaluation, images were taken at 20x following a 24h
exposure. Note that the aggregates of NP can be clearly seen in the higher doses and the
largest size of NP (Ag-55nm). An abundance of NP cannot be seen at the lower doses in
Ag-15 and 30nm images likely because they are not as agglomerated as Ag-55nm and
because the microscope does not allow capturing objects in the nm range. These images
do reveal that NP could associate with the membrane, with the AM’s “surrounding” the
NP. It is believed that the nanoparticles associated with the cell membrane or entering
into cells are likely to have an effect on cellular function. Current data cannot provide
concrete conclusions regarding uptake, although it is known that particles are internalized
by AM within minutes of reaching them (Casarett et al., 2001). Further studies utilizing
Transmission Electron Microscopy (TEM) or Surface Electron Microscopy (SEM) would
provide greater insight on the biological interaction of nanoparticles and provide a
gateway for research targeting specific uptake/interaction pathways.
The results observed for the biochemical endpoints described in this paper
demonstrate that Ag-15 and 30 nm NP increased LDH leakage and reduced MTT
reduction in a dose dependent manner over 24 h exposure duration. Ag-15 and 30 nm
resulted in similar toxicities, but the larger NP, Ag-55 and 130nm, were clearly not as
toxic, suggesting that size plays a role in toxicity. It is believed the smaller nanoparticles
are able to cross the membrane quicker and reach areas of the cell not available to the
larger NP. It is also hypothesized that the Ag-55 and 130 nm were less toxic due to their
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extensive aggregation, as seen in images at both 20x and 100x magnification with the
light microscope. Ag-55 and 130 nm are seen in agglomerates inside of the cells;
however it is unknown whether they agglomerated prior to uptake or intracellularly.
Further, it could be possible that their extensive agglomeration prevented uptake.
Another possible explanation for the difference in toxicity is the hydrocarbon coating on
the nanoparticles. Ag-15 and 30 nm have more coating due to their smaller size and
higher surface area, however, it is not known whether this is the root cause of toxicity or
if it is in fact size-dependent. Based on the MTT and LDH data, it is concluded that size
is the key factor in toxicity. Ag-15 nm stands alone in terms of reducing mitochondrial
function and damaging membrane integrity, two key components to cell viability.
Without functioning mitochondria, cells are unable to exist and function properly.
Decreased membrane integrity combined with images of cells “swelling or becoming
larger after dosing could suggest that the NP induce apoptosis. Although data was not
reported, a single apoptotic assay measuring caspase 3 & 7 activity was conducted and it
was found that Ag 15, 30 and 55 nm NP increased activity by approximately 65, 78 and
40% compared to control (campotecin). This data could be used to provide more insight
to the mechanism of toxicity if coupled with the investigation of the inflammatory
response. A more extensive investigation to correlate oxidative stress with apoptosis and
possibly a lack of inflammatory cytokine production would be beneficial. Since
macrophages are key players in the body’s inflammatory response, further investigation
is deemed necessary.
The final aim of the study was to investigate the hypothesis that exposure to silver
nanoparticles induced oxidative stress. The recent study by Oberdorster (2004) indicated
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that nanomaterials (Fullerenes C60) induced oxidative stress in a fish model, as
demonstrated by a significant elevation of lipid peroxidation and marginal GSH
depletion. Results indicate that ROS generation is significantly increased, even at low
doses of Ag-15 nm. Cells treated with 10 µg/ml Ag-15 nm increased ROS generation by
4.18 ± 2.08 fold. More significant is the extreme increase of ROS generation at the
highest dose, a 15.16±5.77 fold increase. In terms of oxidative stress, each size of
nanoparticle exhibited an average of approximately 2.5-fold increase at 50 µg/ml or
above. It is unknown why Ag-15 nm increased ROS generation by such a greater factor.
When compared to the other sizes, Ag-15 stands alone. To put the data in perspective,
based on a linear regression analysis of H2O2-induced ROS generation, exposure to Ag15 nm at 50 µg/ml is equivalent to ~3,270 µM intracellular H2O2. At 1000 µM H2O2,
intracellular ROS generation was increased by ~5.25-fold. The exact origin of reactive
oxygen species is unknown and it is not the purpose of this data to conclude that H2O2 is
the main species. It is well known that oxidative stress can be induced by the formation
of free radicals, super oxide anion, hydroxyl anion and/or hydrogen peroxide. The
increase of ROS can lead to cell damage throughout the cell or within the specific area
they are produced. However, in dealing with macrophages, ROS generation is an
important part of its defense mechanism. Macrophages induce ROS generation in order
to kill certain bacteria once engulfed. Therefore, it is possible that both the LDH and
ROS data could explain a different method of toxicity. It could be that once exposed to
Ag-NP, the AM’s take on their natural role as scavengers and defenders and internalize
the Ag-NP, internally generating ROS to “kill” the foreign matter. However, the Ag-NP
then act in away that damages the membrane, causing the generated ROS to leak outside
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the cell. Overall, data does suggest that oxidative stress plays a role in toxicity and may
lead to apoptosis. Further studies investigating the activity of antioxidants such as
GSH/GSSG activity would be required to test this hypothesis.
In summary, data suggest that the toxicity of rat alveolar macrophages exposed to
silver nanoparticles is size and dose dependent, with toxicity being ranked as Ag-15>Ag30>Ag-55>Ag-130nm. Further, it is found that smaller sizes (15-30 nm) have significant
affects on mitochondrial function and membrane integrity. ROS were also significantly
increased; suggesting oxidative stress could be the mechanism of toxicity. Microscopic
studies demonstrate cell damage through swelling of cells and the possibility of
attachment and internalization of NP. However, the mechanism by which is NP are
internalized is currently unknown.
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